3OCB

Akt1 kinase domain with pyrrolopyrimidine inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.7 Å
  • R-Value Free: 0.282 
  • R-Value Work: 0.214 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Discovery of pyrrolopyrimidine inhibitors of Akt.

Blake, J.F.Kallan, N.C.Xiao, D.Xu, R.Bencsik, J.R.Skelton, N.J.Spencer, K.L.Mitchell, I.S.Woessner, R.D.Gloor, S.L.Risom, T.Gross, S.D.Martinson, M.Morales, T.H.Vigers, G.P.Brandhuber, B.J.

(2010) Bioorg.Med.Chem.Lett. 20: 5607-5612

  • DOI: 10.1016/j.bmcl.2010.08.053

  • PubMed Abstract: 
  • The discovery and optimization of a series of pyrrolopyrimidine based protein kinase B (Pkb/Akt) inhibitors discovered via HTS and structure based drug design is reported. The compounds demonstrate potent inhibition of all three Akt isoforms and knoc ...

    The discovery and optimization of a series of pyrrolopyrimidine based protein kinase B (Pkb/Akt) inhibitors discovered via HTS and structure based drug design is reported. The compounds demonstrate potent inhibition of all three Akt isoforms and knockdown of phospho-PRAS40 levels in LNCaP cells and tumor xenografts.


    Organizational Affiliation

    Array BioPharma Inc, 3200 Walnut Street, Boulder, CO 80301, USA. jblake@arraybiopharma.com




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
v-akt murine thymoma viral oncogene homolog 1 (AKT1)
A, B
341Homo sapiensMutation(s): 1 
Gene Names: AKT1 (PKB, RAC)
EC: 2.7.11.1
Find proteins for P31749 (Homo sapiens)
Go to Gene View: AKT1
Go to UniProtKB:  P31749
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
GSK 3 beta peptide
C, D
10N/AMutation(s): 0 
Protein Feature View is not available: No corresponding UniProt sequence found.
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
XM1
Query on XM1

Download SDF File 
Download CCD File 
A, B
(2S)-2-(4-chlorobenzyl)-3-oxo-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazin-1-yl]propan-1-amine
C20 H23 Cl N6 O
IYQSFRNHWXBIKV-HNNXBMFYSA-N
 Ligand Interaction
Modified Residues  1 Unique
IDChainsTypeFormula2D DiagramParent
TPO
Query on TPO
A, B
L-PEPTIDE LINKINGC4 H10 N O6 PTHR
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
XM1IC50: 5 nM (99) BINDINGDB
XM1IC50: 5 nM PDBBIND
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.7 Å
  • R-Value Free: 0.282 
  • R-Value Work: 0.214 
  • Space Group: P 1 21 1
Unit Cell:
Length (Å)Angle (°)
a = 86.265α = 90.00
b = 56.013β = 104.27
c = 91.650γ = 90.00
Software Package:
Software NamePurpose
REFMACrefinement
SCALAdata scaling
MOSFLMdata reduction
CrystalCleardata collection
MOLREPphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2010-09-15
    Type: Initial release
  • Version 1.1: 2011-07-13
    Type: Version format compliance